The Unique Challenge of Inpatient Diabetes Management

Hospital stays introduce a cascade of variables that make blood glucose control significantly more difficult than at home. Illness itself triggers a stress response, releasing counter-regulatory hormones such as cortisol, epinephrine, and growth hormone, which can drive glucose levels up sharply. Surgery, anesthesia, infections, and changes in meal timing further compound the instability. For a person with diabetes, even a short hospitalization can lead to dangerous hypoglycemic or hyperglycemic episodes if monitoring and treatment are not meticulously coordinated.

Traditional monitoring methods — intermittent finger-stick checks every few hours — offer only snapshots of a dynamic process. They can miss rapid swings, especially during the night or after a procedure. This is where continuous glucose monitoring (CGM) technology, including devices such as the Diabetic Lens, has the potential to transform inpatient care. By providing a nearly continuous stream of glucose data, these tools empower both patients and clinicians to respond faster and with greater precision.

What Is the Diabetic Lens?

The Diabetic Lens is a wearable CGM system that uses a minimally invasive sensor inserted just under the skin, typically on the upper arm or abdomen. It measures interstitial glucose levels every few minutes and transmits the data wirelessly to a receiver or smartphone app. Unlike older devices that required calibration with finger-sticks, many modern CGM systems are factory-calibrated and can be worn for 10–14 days without replacement.

For hospital use, the Diabetic Lens offers distinct advantages over traditional monitoring. It eliminates the need for repeated finger pricks, reduces nursing workload, and provides trend arrows that indicate whether glucose is rising or falling rapidly. This real-time insight is particularly valuable during surgery, in the intensive care unit, or for patients who are unable to communicate symptoms of hypoglycemia, such as those sedated or with cognitive impairment.

FDA Clearance and Hospital Protocols

While many CGM devices are approved for personal use at home, their use in the hospital setting has historically been limited by regulatory and accuracy concerns. However, in recent years the U.S. Food and Drug Administration (FDA) has cleared certain CGM systems for use in hospitals during the COVID-19 pandemic, and many institutions have since adopted expanded protocols. The Diabetic Lens, if it falls under such clearance, can be used in conjunction with standard point-of-care blood glucose meters — not as a replacement, but as an adjunct to reduce the frequency of finger-sticks and provide early warnings of impending dysglycemia.

Benefits of Continuous Monitoring During a Hospital Stay

Reduced Hypoglycemia Risk

Hypoglycemia (blood glucose below 70 mg/dL) is one of the most feared complications in hospitalized diabetes patients. It can be caused by excessive insulin, missed meals, or unexpected changes in caloric intake after procedures. A CGM system can alert the patient or nursing staff when glucose levels are approaching a dangerous threshold, allowing for a preventive snack or a decrease in insulin infusion rates before the event occurs. Studies have shown that CGM use in hospitals can reduce rates of severe hypoglycemia by up to 40% compared to finger-stick-only protocols.

Better Hyperglycemia Management

Hyperglycemia (blood glucose above 180 mg/dL) is equally dangerous, increasing the risk of surgical site infections, poor wound healing, and longer hospital stays. Continuous data allows clinicians to titrate insulin more aggressively and safely. For example, if a patient’s glucose is trending upward after a corticosteroid dose, the CGM trend can prompt a timely insulin correction rather than waiting for the next scheduled finger-stick.

Enhanced Patient Engagement

Patients who are alert and able to participate in their own care can view their own glucose data on the CGM receiver or phone. This visibility promotes better understanding of how food, activity, and medications affect their glucose, leading to more informed questions and collaboration with the care team. It also reduces the anxiety of “not knowing” between checks.

Reduced Nursing Burden and PPE Use

During outbreaks of infectious diseases, minimizing contact between staff and patients is desirable. A CGM can dramatically reduce the number of times a nurse must enter the room to perform a finger-stick, saving time and conserving personal protective equipment. This was a key driver behind the adoption of CGM in many hospitals during the COVID-19 pandemic.

Potential Limitations and Considerations

Despite its advantages, the Diabetic Lens is not a perfect solution for every hospitalized patient. Accuracy of interstitial glucose measurements can lag behind blood glucose by 5–15 minutes, which may be critical during rapid changes. Sensor failure, dislodgement, or interference from medications (such as acetaminophen or certain antibiotics) can affect readings. Additionally, not all hospital staff are familiar with CGM interpretation; proper training and error-checking protocols are essential.

Patients with severe dehydration, edema, or peripheral hypoperfusion may have unreliable sensor readings. For these reasons, the American Diabetes Association (ADA) recommends that CGM data be confirmed with a finger-stick before making treatment decisions if the sensor reading seems inconsistent with the patient’s clinical picture or if the trend arrow indicates a rapid change.

Practical Steps for Managing Blood Sugar with the Diabetic Lens in the Hospital

Step 1: Pre-Admission Planning

If you or a loved one has an elective surgery or planned hospitalization, discuss the use of CGM with the endocrinologist or hospitalist in advance. Ask whether the hospital allows patient-owned CGM devices. Many hospitals now have policies to accommodate personal CGM, but they may require a doctor’s order and placement of the sensor by a trained nurse. Bring the CGM transmitter, charger, and any necessary supplies. Ensure your phone or receiver is compatible with the hospital’s Wi-Fi or Bluetooth system.

Step 2: Proper Sensor Placement and Calibration

Once admitted, work with the nursing staff to place the Diabetic Lens sensor according to the manufacturer’s instructions. If the device requires calibration with a finger-stick, make sure this is done before the first reading is used for decision-making. Document the time of sensor insertion and any initial calibration values in the medical record. If the sensor alarms or loses connection, notify staff immediately.

Step 3: Daily Communication with the Care Team

During morning rounds, share CGM trends and any alarms you have noted. Ask the team specific questions: “My glucose was dropping during the night — should we adjust the basal insulin?” or “After lunch yesterday, it spiked above 250 — can we modify the meal plan?” The CGM data can be used to fine-tune insulin-to-carbohydrate ratios and correction factors. Many hospitals now incorporate CGM data into the electronic health record (EHR) for seamless review.

Step 4: Coordinating with Nutrition and Meals

Hospital food trays often arrive at scheduled times, but delays can occur due to tests or procedures. Use the CGM trend to anticipate postprandial excursions. If a meal is delayed, the CGM can alert you to the need for a small snack to prevent hypoglycemia from pre-meal insulin. For patients on continuous enteral feeds, CGM helps detect delayed gastric emptying or feed intolerance.

Step 5: Managing Medications That Affect Glucose

Corticosteroids, certain antibiotics, vasopressors, and diuretics can all affect blood glucose levels. The CGM trend can help differentiate between medication-induced hyperglycemia and stress hyperglycemia. Discuss with the pharmacist whether any adjustments to the diabetes regimen are needed. For example, a patient on a high-dose steroid taper might require a temporary increase in insulin matching the daily change in steroid dose.

Step 6: Preparing for Discharge

As the hospital stay nears its end, the CGM data can be downloaded and reviewed to create a safe transition plan. Compare the stability of glucose levels in the hospital to typical home patterns. Ensure the patient has a follow-up appointment with their primary diabetes provider within 7–14 days. If the patient was started on a new insulin regimen during hospitalization, the CGM data can be used to adjust doses for the home environment. Provide written instructions for device use after discharge, including when to insert a new sensor and how to interpret alarms.

Special Situations: Surgery, ICU, and Isolation

Perioperative Period

For patients undergoing surgery, the CGM can be valuable both before and after the procedure. Preoperatively, it helps ensure glucose is in an optimal range (80–180 mg/dL) to reduce surgical infection risk. During surgery, anesthesiologists can monitor glucose trends remotely, but care must be taken because sensor readings may be less accurate during fluid shifts and hypotension. Postoperatively, the CGM can detect the rebound hyperglycemia that often occurs as anesthesia wears off and stress hormones surge.

Intensive Care Unit (ICU)

In the ICU, patients are often sedated and unable to report symptoms. Tight glucose control (140–180 mg/dL) has been shown to improve outcomes, but it requires frequent monitoring. CGM can reduce the burden on ICU nurses and provide earlier warnings of both hypo- and hyperglycemia. However, because of the high risk of inaccurate readings in critically ill patients, most protocols still require periodic confirmation with arterial or capillary blood glucose measurements.

Isolation Precautions (e.g., COVID-19, MRSA)

During isolation, each entry into a room requires full protective gear. A CGM system can significantly reduce the number of entries needed for glucose checks. Some hospitals have set up remote monitoring stations where a single nurse can view CGM data from multiple isolated patients and alert the bedside team only when intervention is needed. This approach conserves PPE and reduces exposure risk.

The Role of Technology and Data Integration

Modern hospitals are increasingly adopting digital health platforms that integrate CGM data with the EHR. This allows physicians, nurses, and dietitians to see glucose trends alongside medication administration records, meal timing, and lab results. The Diabetic Lens, if compatible with such platforms, can provide a comprehensive view that improves clinical decision-making. Patients can also access their own data securely via patient portals, enhancing engagement and education.

However, challenges remain. Not all EHR systems are built to ingest high-frequency CGM data. Alarms from consumer-grade CGM devices can create alert fatigue in a busy hospital environment. Institutions must set appropriate thresholds for alerts and route them to the right staff member — for instance, a low-glucose alert should go to the bedside nurse, while a pattern of hyperglycemia might be flagged for the endocrinology consult team.

Choosing the Right Device: Is the Diabetic Lens Right for You?

The Diabetic Lens is one of several CGM options on the market. When considering whether to use it during a hospital stay, factors such as sensor accuracy, wear time, integration with hospital systems, and cost should be weighed. Some devices offer a disposable all-in-one sensor/transmitter that requires no charging, while others have reusable transmitters that must be recharged every 7–10 days. The choice may also depend on what the patient already uses at home — continuity is helpful for training and data comparison.

Patients should consult with their diabetes care team to determine if CGM is appropriate for their specific hospitalization. In most cases, it can be used safely alongside standard monitoring, but for patients with type 1 diabetes who are at high risk of diabetic ketoacidosis (DKA) or those with gastroparesis, a CGM can be a life-saving tool. For type 2 diabetes on a simple regimen, standard finger-sticks may suffice.

Future Directions: Closed-Loop Systems in the Hospital

The next frontier in inpatient glucose management is the use of automated insulin delivery (AID) systems — often called artificial pancreas or closed-loop systems. These combine a CGM with an insulin pump and a control algorithm that adjusts insulin delivery automatically. While most AID systems are currently approved for home use only, clinical trials are underway in hospitals. The Diabetic Lens could potentially be integrated into such a system, offering a fully automated solution for diabetes management during surgery or critical illness.

Early results are promising: studies show that closed-loop systems can achieve a higher percentage of time in target glucose range (70–180 mg/dL) compared to standard care, with lower risk of hypoglycemia. As regulatory pathways evolve, hospitals may soon adopt these systems for selected patients, further reducing the burden on nursing staff and improving patient safety.

Conclusion: A Data-Driven Approach to Inpatient Diabetes Care

Hospital stays are a high-risk period for people with diabetes, but continuous glucose monitoring technology such as the Diabetic Lens offers a powerful tool to navigate those risks. By providing real-time trends, early warnings, and a wealth of data for clinical decisions, CGM can help maintain glucose stability, reduce complications, and shorten hospital stays. The key to success lies in proper education, clear protocols, and strong communication between the patient and the care team.

Patients should be proactive: discuss CGM options before admission, ensure correct sensor placement, and actively share trend data during daily rounds. Healthcare institutions should invest in training staff to interpret CGM data and integrate it into the EHR. With these pieces in place, the Diabetic Lens and similar devices can turn a traditionally reactive form of glucose management into a proactive, continuous, and collaborative process — ultimately leading to safer, more comfortable hospital experiences for individuals living with diabetes.

For further reading, consult the American Diabetes Association’s hospital admission guidelines and the CDC’s sick-day management tips for diabetes. A recent review in Diabetes Technology & Therapeutics provides an overview of CGM use in hospital settings.